[1] |
FORBES J D, VAN DOMSELAAR G, BERNSTEIN C N. The gut microbiotain immune-mediated inflammatory diseases[J]. Front Microbiol, 2016,7:1081.
|
[2] |
LUCAS LÓPEZ R, GRANDE BURGOS M J, GÁLVEZ A, et al. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease:a state of the science review[J]. APMIS, 2017,125(1):3-10.
DOI
URL
|
[3] |
PAGLIARI D, PICCIRILLO C A, LARBI A, et al. The interactions between innate immunity and microbiota in gastrointestinal diseases[J]. J Immunol Res, 2015,2015:898297.
|
[4] |
JANDHYALA S M, TALUKDAR R, SUBRAMANYAM C, et al. Role of the normal gut microbiota[J]. World J Gastroenterol, 2015,21(29):8787-8803.
DOI
URL
|
[5] |
SARTOR R B, WU G D. Roles for intestinal bacteria,viruses,and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches[J]. Gastroenterology, 2017, 152(2):327-339.e4.
DOI
URL
|
[6] |
SIGNORETTI M, ROGGIOLANI R, STORNELLO C, et al. Gut microbiota and pancreatic diseases[J]. Minerva Gastroenterol Dietol, 2017,63(4):399-410.
|
[7] |
PUSHALKAR S, HUNDEYIN M, DALEY D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018,8(4):403-416.
DOI
URL
|
[8] |
LESINA M, WÖRMANN S M, NEUHÖFER P, et al. Interleukin-6 in inflammatory and malignant diseases of the pancreas[J]. Semin Immunol, 2014,26(1):80-87.
DOI
URL
|
[9] |
HABERMAN Y, TICKLE T L, DEXHEIMER P J, et al. Pediatric crohn disease patients exhibit specific ileal transcriptome and microbiome signature[J]. J Clin Invest, 2014,124(8):3617-3633.
DOI
URL
|
[10] |
WLODARSKA M, KOSTIC A D, XAVIER R J. An integrative view of microbiome-host interactions in inflammatory bowel diseases[J]. Cell Host Microbe, 2015,17(5):577-591.
DOI
URL
|
[11] |
ROOKS M G, GARRETT W S. Gut microbiota,metabolites and host immunity[J]. Nat Rev Immunol, 2016,16(6):341-352.
DOI
URL
|
[12] |
CLEMENTE J C, MANASSON J, SCHER J U. The role of the gut microbiome in systemic inflammatory disease[J]. BMJ, 2018,360:j5145.
|
[13] |
YU J, LIU Y, GUO J, et al. Health risk of Licorice-Yuanhua combination through induction of colonic H2S metabolism[J]. J Ethnopharmacol, 2019,236:136-146.
DOI
URL
|
[14] |
WHITCOMB D C. Clinical practice. Acute pancreatitis[J]. N Engl J Med, 2006,354(20):2142-2150.
DOI
URL
|
[15] |
SCHÜTTE K, MALFERTHEINER P. Markers for predicting severity and progression of acute pancreatitis[J]. Best Pract Res Clin Gastroenterol, 2008,22(1):75-90.
DOI
URL
|
[16] |
RINDERKNECHT H. Fatal pancreatitis,a consequence of excessive leukocyte stimulation?[J]. Int J Pancreatol, 1988,3(2-3):105-112.
|
[17] |
WAAGE A, BRANDTZAEG P, HALSTENSEN A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6,interleukin 1,and fatal outcome[J]. J Exp Med, 1989,169(1):333-338.
DOI
URL
|
[18] |
SUZUKI S, MIYASAKA K, JIMI A, et al. Induction of acute pancreatitis by cerulein in human IL-6 gene transgenic mice[J]. Pancreas, 2000,21(1):86-92.
DOI
URL
|
[19] |
ZHANG H, NEUHÖFER P, SONG L, et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality[J]. J Clin Invest, 2013,123(3):1019-1031.
DOI
URL
|
[20] |
ROBERTS S E, MORRISON-REES S, JOHN A, et al. The incidence and aetiology of acutepancreatitis across Europe[J]. Pancreatology, 2017,17(2):155-165.
DOI
URL
|
[21] |
PETROV M S, YADAV D. Global epidemiology and holistic prevention of pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019,16(3):175-184.
DOI
URL
|
[22] |
LERCH M M, GORELICK F S. Models of acute and chronic pancreatitis[J]. Gastroenterology, 2013,144(6):1180-1193.
DOI
URL
|
[23] |
PUSHALKAR S, HUNDEYIN M, DALEY D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018,8(4):403-416.
DOI
URL
|
[24] |
ANDERSSON R, WANG X D. Gut barrier dysfunction in experimental acute pancreatitis[J]. Ann Acad Med Singap, 1999,28(1):141-146.
|
[25] |
TAN C, LING Z, HUANG Y, et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas, 2015,44(6):868-875.
DOI
URL
|
[26] |
WU L M, SANKARAN S J, PLANK L D, et al. Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis[J]. Br J Surg, 2014,101(13):1644-1656.
DOI
URL
|
[27] |
LI Q, WANG C, TANG C, et al. Bacteremia in patients with acute pancreatitis as revealed by 16S ribosomal RNA gene-based techniques[J]. Crit Care Med, 2013,41(8):1938-1950.
DOI
URL
|
[28] |
TSUJI Y, WATANABE T, KUDO M, et al. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis[J]. Immunity, 2012,37(2):326-338.
DOI
URL
|
[29] |
CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health:an integrative view[J]. Cell, 2012,148(6):1258-1270.
DOI
URL
|
[30] |
YU Y, RAKA F, ADELI K. The role of the gut microbiota in lipid and lipoprotein metabolism[J]. J Clin Med, 2019,8(12):2227.
DOI
URL
|
[31] |
MATEY-HERNANDEZ M L, WILLIAMS F M K, POTTER T, et al. Genetic and microbiome influence on lipid metabolism and dyslipidemia[J]. Physiol Genom, 2018,50(2):117-126.
DOI
URL
|
[32] |
WANG Z, KOONEN D, HOFKER M, et al. Gut microbiome and lipid metabolism:from associations to mechanisms[J]. Curr Opin Lipidol, 2016,27(3):216-224.
DOI
URL
|
[33] |
FASSHAUER M, BLÜHER M. Adipokines in health and disease[J]. Trends Pharmacol Sci, 2015,36(7):461-470.
DOI
URL
|
[34] |
BLÜHER M. Adipokines-removing road blocks to obesity and diabetes therapy[J]. Mol Metab, 2014,3(3):230-240.
DOI
URL
|
[35] |
SKURK T, ALBERTI-HUBER C, HERDER C, et al. Relationship between adipocyte size and adipokine expression and secretion[J]. J Clin Endocrinol Metab, 2007,92(3):1023-1033.
DOI
URL
|